Download PDF
J Neurol Surg B Skull Base 2021; 82(06): 638-642
DOI: 10.1055/s-0040-1715812
Original Article

Temporal Bone Adenoma: A Comprehensive Analysis of Clinical Aspects and Surgical Outcome on a Very Rare Entity

Hussain Alsalman
1   Department of Otorhinolaryngology, Queen Elizabeth University Hospital, Glasgow, United Kingdom
2   Medical School, King Saud University, Riyadh, Saudi Arabia
,
John A. Crowther
1   Department of Otorhinolaryngology, Queen Elizabeth University Hospital, Glasgow, United Kingdom
,
Douglas McLellan
3   Department of Pathology, Queen Elizabeth University Hospital, Glasgow, United Kingdom
,
Georgios Kontorinis
1   Department of Otorhinolaryngology, Queen Elizabeth University Hospital, Glasgow, United Kingdom
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Objective The aim of this study is to present our experience in dealing with middle ear adenomas (MEAs), very rare tumors of the middle ear.

Methods The medical notes of individuals with MEAs treated in tertiary referral; academic settings were retrospectively reviewed. We recorded the presenting symptoms, imaging findings, and pathology results. We additionally examined our surgical outcomes, follow-up period, recurrence, and morbidity.

Results We identified four patients with MEAs: two males and two females with an average age of 36.25 years (range = 27–51 years). Despite the detailed imaging studies, including computed tomography and magnetic resonance imaging with intravenous contrast administration, a biopsy was essential in setting the diagnosis. Total surgical resection was achieved in all patients without any recurrence over an average of 6 years (range = 3–10 years). Complete ipsilateral deafness was the commonest surgical morbidity due to footplate infiltration by the tumor.

Conclusion Total surgical resection is the treatment of choice in MEAs to minimize the risk for recurrence; this can come with morbidity, mostly sensorineural deafness. Given the very limited literature, long-term follow-up is recommended.

Keywords

adenoma - facial nerve - mastoid - middle ear tumor


Publication History

Received: 06 March 2020

Accepted: 02 June 2020

Article published online:
05 October 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Torske KR, Thompson LDR. Adenoma versus carcinoid tumor of the middle ear: a study of 48 cases and review of the literature. Mod Pathol 2002; 15 (05) 543-555
    CrossrefPubMedGoogle Scholar
  • 2 Cardoso FA, Monteiro EMR, Lopes LB, Avila MNDC, Scarioli BO. Adenomatous tumors of the middle ear: a literature review. Int Arch Otorhinolaryngol 2017; 21 (03) 308-312
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Kim YH, Lee SH, Jung DJ. Neuroendocrine adenoma of the middle ear confused with congenital cholesteatoma. Rev Bras Otorrinolaringol (Engl Ed) 2014; 80 (02) 180-181
    PubMedGoogle Scholar
  • 4 Kikuchi S, Sakumoto M, Okabe Y, Furukawa M. A case of middle ear adenoma. Pract Otol Suppl 1995; 1995: 28-33
    PubMedGoogle Scholar
  • 5 Isenring D, Pezier TF, Vrugt B, Huber AM. Middle ear adenoma: case report and discussion. Case Rep Otolaryngol 2014; 2014: 342125
    PubMedGoogle Scholar
  • 6 Wang L, Ouyang N, Guo HX, Liu QY. Middle ear adenoma with uncommon presentation and literature review. BMJ Case Rep 2017; 2017: bcr-2016-216694
    CrossrefPubMedGoogle Scholar
  • 7 Saliba I, Evrard AS. Middle ear glandular neoplasms: adenoma, carcinoma or adenoma with neuroendocrine differentiation: a case series. Cases J 2009; 2: 6508
    CrossrefPubMedGoogle Scholar
  • 8 Hu H, Lim WY, Tan TY, Yuen HW. Neuroendocrine adenoma of middle ear with new bone formation and review of literature. Am J Otolaryngol 2016; 37 (02) 108-111
    CrossrefPubMedGoogle Scholar